According to the latest report by IMARC Group, titled Pyrogen Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global pyrogen testing market reached a value of US$ 1.10 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.04 Billion by 2027, exhibiting at a CAGR of 10.7% during 2022-2027.

Pyrogen testing refers to the detection of both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in the safety of parenteral pharmaceutical products and medical devices. Pyrogen testing aids in avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some commonly used methods of pyrogen testing include the Limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), etc.

Request for a free sample copy of this report: https://www.imarcgroup.com/pyrogen-testing-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The expanding pharmaceutical and biotechnology industries are primarily driving the pyrogen testing market. Furthermore, pyrogen testing aids in enhancing the management of infectious diseases by determining the disease severity, recovery, and sequelae, along with being used in the production of novel COVID-19 vaccines. This, in turn, is also propelling the market growth. Besides this, the growing prevalence of chronic ailments, including heart diseases, cancer, diabetes, etc., is further augmenting the growth of the market. Moreover, several key players are introducing technologically advanced and cost-effective pyrogen testing techniques that provide a more relevant prediction of pyrogenic activity. In addition to this, the launch of the new therapeutics and extensive R&D activities by manufacturing companies are further anticipated to catalyze the pyrogen testing market in the coming years.

Breakup by Product:

  • Instruments
  • Kits and Reagents
  • Services

Breakup by Test Type:

  • In-vitro Tests
  • LAL Tests
  • Rabbit Tests
  • Others

Breakup by Application:

  • Pharmaceutical and Biologics
  • Medical Devices
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Charles River Laboratories International Inc
  • Ellab A/S
  • Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
  • Lonza Group AG
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Nelson Laboratories LLC (Sotera Health)
  • North American Science Associates Inc
  • Pacific Biolabs Inc
  • Sanquin
  • Thermo Fisher Scientific Inc
  • Toxikon Corporation
  • Wuxi Apptec

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pyrogen-testing-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800